<DOC>
	<DOCNO>NCT00415376</DOCNO>
	<brief_summary>RATIONALE : Anticonvulsant drug , levetiracetam , may help control seizure cause brain metastasis . PURPOSE : This clinical trial study side effect well levetiracetam work treat patient seizure cause brain metastasis .</brief_summary>
	<brief_title>Levetiracetam Treating Patients With Seizures Caused Brain Metastases</brief_title>
	<detailed_description>OBJECTIVES : - Determine optimal dose levetiracetam require control seizures brain metastasis patient solid tumor . - Determine frequency side effect tolerability drug use control seizures patient . - Determine improvement antiepileptic drug-associated symptom patient . OUTLINE : This pilot study . Patients stratify accord baseline seizure ( yes v ) and/or baseline antiepileptic drug ( AEDs ) ( yes v ) . Patients assign 1 3 treatment group . - Group I ( patient active baseline seizure ) : Patients receive oral levetiracetam twice daily begin day 1 . - Group II ( patient require IV AEDs baseline seizure control ) : Patients receive oral levetiracetam ( instead current anticonvulsant therapy ) twice daily begin day 1 , present condition stabilize . - Group III ( patient active seizure control concurrent anticonvulsant monotherapy ) : Patients receive oral levetiracetam ( instead current anticonvulsant therapy ) twice daily begin day 1 . Treatment anticonvulsant drug taper begin day 3 direct treat physician . In group , treatment continue 6 month absence uncontrolled seizure unacceptable toxicity . During study therapy , patient maintain seizure log track frequency type seizure . Any patient experience breakthrough seizure multiple auras receives increase dos oral levetiracetam maximum dose reach . Patients continue seizure maximum dose level receive second antiseizure medication discretion treat physician . Quality life assess Fundamental Assessment Cancer Treatment-Brain questionnaire baseline 2 month . PROJECTED ACCRUAL : A total 30 patient accrue study .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm solid tumor Pathological confirmation brain metastasis require provide clinical neuroradiographic picture typical Has least one prior seizure due brain metastasis PATIENT CHARACTERISTICS : Life expectancy ≥ 12 week Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Absolute neutrophil count ≥ 1,500/mm³ Platelet count ≥ 100,000/mm³ Hemoglobin ≥ 10 g/dL BUN &lt; 5 time upper limit normal ( ULN ) Creatinine &lt; 5 time ULN Bilirubin &lt; 1.5 time ULN AST ALT ≤ 3 time ULN Alkaline phosphatase ≤ 2 time ULN No allergy levetiracetam PRIOR CONCURRENT THERAPY : Prior levetiracetam allow provide initiate within past 14 day Other concurrent anticonvulsant monotherapy allow provided therapy initiate within past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>seizure</keyword>
	<keyword>adult tumor metastatic brain</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>